ReviewBioMed research international2018
Benralizumab: From the Basic Mechanism of Action to the Potential Use in the Biological Therapy of Severe Eosinophilic Asthma.
Corrado Pelaia et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
63 papers cite itlatest 60 shown
this paperpooled ittrialcites it